Publication | Closed Access
Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21
58
Citations
42
References
2016
Year
UrologyMedicineCancer BiologyAnti-cancer AgentTumor SuppressorEllagitannin-derived MetaboliteProstatic DiseasePharmacologyTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1